|
AU2012232984A1
|
|
Methods and devices for providing prolonged drug therapy
|
|
US2011229533A1
|
|
Extended release dosage form
|
|
AU2009320181A1
|
|
Extended release oral acetaminophen/tramadol dosage form
|
|
US2010004583A1
|
|
Hydrophobic Circuit Board Coating of Electrotransport Drug Delivery Devices
|
|
WO2009149150A2
|
|
Composition comprising liposome-entrapped doxorubicin and methods of administration
|
|
US2009312689A1
|
|
Adjustable Current Electrotransport Fentanyl Delivery Device
|
|
WO2009155135A1
|
|
Composition comprising liposome-entrapped doxorubicin and methods of admnistration for treatment of multiple myeloma
|
|
WO2009123970A2
|
|
Electrotransport fentanyl delivery device with consistent delivery
|
|
WO2009120840A2
|
|
Humidity controlling absorber for electrotransport drug delivery devices
|
|
WO2009054988A1
|
|
Transdermal sustained release drug delivery
|
|
US2009136554A1
|
|
Transdermal sustained release drug delivery
|
|
US2009105634A1
|
|
Anodic Reservoir for Electrotransport of Cationic Drug
|
|
WO2009051994A2
|
|
Electrotransport of lisuride
|
|
BRPI0815613A2
|
|
Liposomal compositions for in vivo administration of boronic acid compounds.
|
|
MX2010002101A
|
|
Liposome formulations of boronic acid compounds.
|
|
WO2009026135A2
|
|
Controlled transdermal bisoprolol delivery system
|
|
WO2009026133A2
|
|
Transdermal bisoprolol delivery system
|
|
WO2009021128A1
|
|
Electrotransport drug delivery device adaptable to skin resistance change
|
|
WO2008116105A1
|
|
Pivotally engaged multiple part electrotransport drug delivery device
|
|
CA2682216A1
|
|
Multiple part electrotransport drug delivery device
|
